← Back to Vulnerability Reports CVE Intelligence

CVE-2026-85102

Check Point Multiple Products•CRITICAL · CVSS 9.8• In the wild In CISA KEV

What is CVE-2026-85102?

Improper certificate trust validation during VPN negotiation in Check Point Quantum Security Gateway may allow an unauthenticated remote attacker to execute arbitrary code on the Gateway.

CVSS9.8 NVD 3.1
SeverityCRITICAL
Exploitation In the wild In CISA KEV
EPSS54% · P99
Triage statusActive Exploit
ActionPatch immediately
CVSS vectorCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H
CWECWE-295
NVD published2026-09-09
NVD last modified2026-09-23

Timeline

  • 2026-09-09Published to the U.S. National Vulnerability Database (NVD)
  • 2026-09-14First covered in a defend.network daily briefing
  • 2026-09-22Added to the CISA Known Exploited Vulnerabilities (KEV) catalog
  • 2026-09-23NVD record last updated
  • 2026-09-25CISA federal remediation deadline (BOD 22-01)

CISA Known Exploited Vulnerability

Check Point Multiple Products Improper Certificate Validation Vulnerability

Added to KEV2026-09-22
Federal patch deadline2026-09-25
Known ransomware useUnknown

Affected product

Check Point Multiple Products

NVD also lists CPE entries for: Checkpoint Gaia Embedded, Checkpoint Quantum Spark 1530, Checkpoint Quantum Spark 1535, Checkpoint Quantum Spark 1550, Checkpoint Quantum Spark 1555

Remediation Steps

  1. Apply the vendor security update for Check Point Security Gateway, Check Point Spark Firewall as a priority.
  2. Restrict network exposure of the affected service to trusted sources until patched.
  3. Review logs and detections for indicators of exploitation.
  4. Confirm fixed versions against the official vendor advisory before deploying.

Related vulnerabilities

Browse all tracked CVEs in the defend.network CVE database →

🤖 This CVE page is generated by defend.network from NVD, CISA KEV, EPSS, and our verified daily briefings. Severity and exploitation data come from official sources; always verify remediation steps against the official vendor advisory before acting in production.